Neckcin 500mg Injection

Neckcin 500mg Injection is a potent macrolide antibacterial agent formulated for intravenous administration, targeting a broad spectrum of bacterial infections. Containing Azithromycin 500mg, this pharmaceutical product is designed for healthcare professionals to manage moderate to severe infections where oral therapy may not be suitable or initial intravenous treatment is required.

Azithromycin, the active ingredient, functions by inhibiting bacterial protein synthesis, thereby arresting bacterial growth and preventing the spread of infection. This mechanism of action makes it effective against various susceptible microorganisms, providing a critical therapeutic option in clinical settings.

Primarily indicated for adult patients, Neckcin 500mg Injection is a vital treatment in conditions such as Community-Acquired Pneumonia (CAP) and Pelvic Inflammatory Disease (PID). Its targeted efficacy also extends to other bacterial infections of the respiratory tract, skin, and soft tissues, as well as for the prophylaxis of Mycobacterium avium complex (MAC) disease in specific patient populations.

Key Features : 

Broad-spectrum macrolide antibiotic for effective bacterial eradication
Formulated as a lyophilized powder for reconstitution and intravenous infusion
Indicated for severe bacterial infections including Community-Acquired Pneumonia and Pelvic Inflammatory Disease
Inhibits bacterial protein synthesis to stop growth and spread of infection
Suitable for adult patients requiring initial intravenous therapy
Not for bolus or intramuscular injection, ensuring controlled administration